SATIOGEN PHARMACEUTICALS
Satiogen Pharmaceuticals is a specialty pharma company focused on novel-target for treating type 2 diabetes. The company's metabolic mechanism therapy offers designed to regulate nutrient intake and postprandial glucose. The company's products include a substitute for metformin in gliptin formulations and an OTC nutraceutical that would reduce body weight and postprandial glucose, enabling doctors to treat type 2 diabetes and obesity without intervention.
SATIOGEN PHARMACEUTICALS
Founded:
2007-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.satiogen.com
Status:
Active
Total Funding:
700 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Euro Typekit Squarespace Squarespace Add To Cart
Current Employees Featured
Founder
